Cost-effectiveness of different human papillomavirus vaccines in Singapore

BACKGROUND: Human papillomavirus (HPV) vaccines are widely available and there have been studies exploring their potential clinical impact and cost-effectiveness. However, few studies have compared the cost-effectiveness among the 2 main vaccines available - a bivalent vaccine against HPV 16/18, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Vernon J, Tay, Sun Kuie, Teoh, Yee Leong, Tok, Mei Yin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082243/
https://www.ncbi.nlm.nih.gov/pubmed/21453537
http://dx.doi.org/10.1186/1471-2458-11-203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082243/
https://www.ncbi.nlm.nih.gov/pubmed/21453537
http://dx.doi.org/10.1186/1471-2458-11-203

Ejemplares similares